COVID-19 and Pulmonary Thrombosis—An Unresolved Clinical Puzzle: A Single-Center Cohort Study

Pulmonary thrombosis (PT) is a frequent complication of COVID-19. However, the risk factors, predictive scores, and precise diagnostic guidelines on indications for CT pulmonary angiography (CTPA) are still lacking. This study aimed to analyze the clinical and laboratory characteristics associated w...

Full description

Bibliographic Details
Main Authors: Loris Močibob, Frano Šušak, Maja Šitum, Klaudija Višković, Neven Papić, Adriana Vince
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/23/7049
_version_ 1797462937261047808
author Loris Močibob
Frano Šušak
Maja Šitum
Klaudija Višković
Neven Papić
Adriana Vince
author_facet Loris Močibob
Frano Šušak
Maja Šitum
Klaudija Višković
Neven Papić
Adriana Vince
author_sort Loris Močibob
collection DOAJ
description Pulmonary thrombosis (PT) is a frequent complication of COVID-19. However, the risk factors, predictive scores, and precise diagnostic guidelines on indications for CT pulmonary angiography (CTPA) are still lacking. This study aimed to analyze the clinical and laboratory characteristics associated with PT in patients with COVID-19. We conducted a cohort study of consecutively hospitalized adult patients with COVID-19 who underwent CTPA at the University Hospital for Infectious Diseases in Zagreb, Croatia between 1 April and 31 December 2021. Of 2078 hospitalized patients, 575 (27.6%) underwent CTPA. PT was diagnosed in 178 (30.9%) patients (69.6% males, median age of 61, IQR 50–69 years). The PT group had a higher CRP, LDH, D-dimer, platelets, and CHOD score. PT was more frequent in patients requiring ≥15 L O<sub>2</sub>/min (25.0% vs. 39.7%). In multivariable analysis, only D-dimer ≥ 1.0 mg/L (OR 1.78, 95%CI 1.12–2.75) and O<sub>2</sub> ≥ 15 L (OR 1.89, 95%CI 1.26–2.84) were associated with PT. PT was not associated with in-hospital mortality. In conclusion, our data confirmed a high incidence of PT in hospitalized patients with COVID-19, however, no correlation with traditional risk factors and mortality was found. CTPA should be performed in patients requiring high-flow supplemental oxygen or those with increased D-dimer levels.
first_indexed 2024-03-09T17:43:36Z
format Article
id doaj.art-73eb541da7134075a3f19024adc3ad49
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T17:43:36Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-73eb541da7134075a3f19024adc3ad492023-11-24T11:22:03ZengMDPI AGJournal of Clinical Medicine2077-03832022-11-011123704910.3390/jcm11237049COVID-19 and Pulmonary Thrombosis—An Unresolved Clinical Puzzle: A Single-Center Cohort StudyLoris Močibob0Frano Šušak1Maja Šitum2Klaudija Višković3Neven Papić4Adriana Vince5Department for Viral Hepatitis, University Hospital for Infectious Diseases Zagreb, Mirogojska 8, 10000 Zagreb, CroatiaDepartment of Infectious Diseases, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Infectious Diseases, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment for Radiology and Ultrasound Diagnostics, University Hospital for Infectious Diseases Zagreb, Mirogojska 8, 10000 Zagreb, CroatiaDepartment for Viral Hepatitis, University Hospital for Infectious Diseases Zagreb, Mirogojska 8, 10000 Zagreb, CroatiaDepartment for Viral Hepatitis, University Hospital for Infectious Diseases Zagreb, Mirogojska 8, 10000 Zagreb, CroatiaPulmonary thrombosis (PT) is a frequent complication of COVID-19. However, the risk factors, predictive scores, and precise diagnostic guidelines on indications for CT pulmonary angiography (CTPA) are still lacking. This study aimed to analyze the clinical and laboratory characteristics associated with PT in patients with COVID-19. We conducted a cohort study of consecutively hospitalized adult patients with COVID-19 who underwent CTPA at the University Hospital for Infectious Diseases in Zagreb, Croatia between 1 April and 31 December 2021. Of 2078 hospitalized patients, 575 (27.6%) underwent CTPA. PT was diagnosed in 178 (30.9%) patients (69.6% males, median age of 61, IQR 50–69 years). The PT group had a higher CRP, LDH, D-dimer, platelets, and CHOD score. PT was more frequent in patients requiring ≥15 L O<sub>2</sub>/min (25.0% vs. 39.7%). In multivariable analysis, only D-dimer ≥ 1.0 mg/L (OR 1.78, 95%CI 1.12–2.75) and O<sub>2</sub> ≥ 15 L (OR 1.89, 95%CI 1.26–2.84) were associated with PT. PT was not associated with in-hospital mortality. In conclusion, our data confirmed a high incidence of PT in hospitalized patients with COVID-19, however, no correlation with traditional risk factors and mortality was found. CTPA should be performed in patients requiring high-flow supplemental oxygen or those with increased D-dimer levels.https://www.mdpi.com/2077-0383/11/23/7049pulmonary thrombosisCOVID-19D-dimerpulmonary angiographyCTPAvenous thromboembolism
spellingShingle Loris Močibob
Frano Šušak
Maja Šitum
Klaudija Višković
Neven Papić
Adriana Vince
COVID-19 and Pulmonary Thrombosis—An Unresolved Clinical Puzzle: A Single-Center Cohort Study
Journal of Clinical Medicine
pulmonary thrombosis
COVID-19
D-dimer
pulmonary angiography
CTPA
venous thromboembolism
title COVID-19 and Pulmonary Thrombosis—An Unresolved Clinical Puzzle: A Single-Center Cohort Study
title_full COVID-19 and Pulmonary Thrombosis—An Unresolved Clinical Puzzle: A Single-Center Cohort Study
title_fullStr COVID-19 and Pulmonary Thrombosis—An Unresolved Clinical Puzzle: A Single-Center Cohort Study
title_full_unstemmed COVID-19 and Pulmonary Thrombosis—An Unresolved Clinical Puzzle: A Single-Center Cohort Study
title_short COVID-19 and Pulmonary Thrombosis—An Unresolved Clinical Puzzle: A Single-Center Cohort Study
title_sort covid 19 and pulmonary thrombosis an unresolved clinical puzzle a single center cohort study
topic pulmonary thrombosis
COVID-19
D-dimer
pulmonary angiography
CTPA
venous thromboembolism
url https://www.mdpi.com/2077-0383/11/23/7049
work_keys_str_mv AT lorismocibob covid19andpulmonarythrombosisanunresolvedclinicalpuzzleasinglecentercohortstudy
AT franosusak covid19andpulmonarythrombosisanunresolvedclinicalpuzzleasinglecentercohortstudy
AT majasitum covid19andpulmonarythrombosisanunresolvedclinicalpuzzleasinglecentercohortstudy
AT klaudijaviskovic covid19andpulmonarythrombosisanunresolvedclinicalpuzzleasinglecentercohortstudy
AT nevenpapic covid19andpulmonarythrombosisanunresolvedclinicalpuzzleasinglecentercohortstudy
AT adrianavince covid19andpulmonarythrombosisanunresolvedclinicalpuzzleasinglecentercohortstudy